Orchestra BioMed Holdings, Inc. SEC filings OBIO
Orchestra BioMed Holdings, Inc. has 412 filings in SEC EDGAR's recent list, going back to Jun 22, 2020. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Nov 5, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 1, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2026 | Sep 8, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2026 | Jun 23, 2026 |
| S-8 | Employee stock plan registration | Jun 23, 2026 | — |
| DEFA14A | Additional proxy material | Jun 16, 2026 | — |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 23, 2026 |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 13, 2026 | Feb 12, 2026 |
| S-8 | Employee stock plan registration | Feb 6, 2026 | — |
| S-8 | Employee stock plan registration | Feb 6, 2026 | — |
| 8-K |
Current report
Other events
|
Jan 12, 2026 | Jan 12, 2026 |
| 424B3 | Prospectus | Nov 21, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 13, 2025 | Nov 12, 2025 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| S-3 | Shelf registration | Oct 31, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 30, 2025 | Oct 30, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale, Regulation FD disclosure, Other events
|
Oct 28, 2025 | Oct 24, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Aug 4, 2025 | Jul 31, 2025 |
| 424B5 | Prospectus supplement | Aug 1, 2025 | — |
| 424B5 | Prospectus supplement | Jul 31, 2025 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure, Other events
|
Jul 31, 2025 | Jul 31, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2025 | Jun 24, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Apr 30, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 29, 2025 | Apr 29, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 3, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 25, 2025 | Feb 19, 2025 |
| S-8 | Employee stock plan registration | Feb 19, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 5, 2025 | Jan 30, 2025 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Other events
|
Aug 12, 2024 | Aug 12, 2024 |
| 424B5 | Prospectus supplement | Aug 12, 2024 | — |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 30, 2024 | Jul 29, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 11, 2024 | Jun 11, 2024 |
| EFFECT | Filing | May 24, 2024 | — |
| 424B3 | Prospectus | May 24, 2024 | — |
| CORRESP | Letter to the SEC | May 22, 2024 | — |
| UPLOAD | Letter from the SEC | May 20, 2024 | — |
| S-3 | Shelf registration | May 15, 2024 | — |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| EFFECT | Filing | May 9, 2024 | — |
| 424B3 | Prospectus | May 9, 2024 | — |
| CORRESP | Letter to the SEC | May 8, 2024 | — |
| ARS | Annual report to shareholders | Apr 30, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 30, 2024 | — |
| DEF 14A | Proxy statement | Apr 30, 2024 | Jun 20, 2024 |
| CORRESP | Letter to the SEC | Apr 25, 2024 | — |
| S-3/A | Filing | Apr 25, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 18, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 29, 2024 | Mar 29, 2024 |
| S-8 | Employee stock plan registration | Mar 27, 2024 | — |
| CORRESP | Letter to the SEC | Mar 27, 2024 | — |
| S-3/A | Filing | Mar 27, 2024 | — |
| 10-K | Annual report | Mar 27, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 7, 2024 | Mar 6, 2024 |
| 8-K |
Current report
Material agreement
|
Nov 28, 2023 | Nov 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 14, 2023 | Nov 14, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| UPLOAD | Letter from the SEC | Oct 24, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 10, 2023 | Oct 10, 2023 |
| S-1 | Registration statement | Oct 10, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 19, 2023 | Sep 19, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K/A |
Amended current report
Regulation FD disclosure
|
Jul 13, 2023 | Jul 12, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 12, 2023 | Jul 12, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Jun 8, 2023 | Jun 5, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 8, 2023 | Jun 8, 2023 |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| S-8 | Employee stock plan registration | Apr 3, 2023 | — |
| 8-K/A |
Amended current report
Results of operations
|
Mar 24, 2023 | Jan 25, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 13, 2023 | Mar 13, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Jan 31, 2023 | Jan 25, 2023 |
| 10-K | Annual report | Jan 25, 2023 | Dec 31, 2022 |
| 425 | Current report | Jan 25, 2023 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Jan 25, 2023 | Jan 24, 2023 |
| 8-K |
Current report
Listing notice
|
Jan 24, 2023 | Jan 19, 2023 |
| 8-K |
Current report
Other events
|
Jan 24, 2023 | Jan 20, 2023 |
| 425 | Form 425 | Jan 10, 2023 | — |
| 8-K |
Current report
Change to shareholder rights
|
Dec 21, 2022 | Dec 15, 2022 |
| EFFECT | Filing | Dec 16, 2022 | — |
| 424B3 | Prospectus | Dec 16, 2022 | — |
| SEC STAFF LETTER | Filing | Dec 16, 2022 | — |
| CORRESP | Letter to the SEC | Dec 15, 2022 | — |
| CORRESP | Letter to the SEC | Dec 15, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 15, 2022 | — |
| S-4/A | Amendment no. 4 to form s-4 | Dec 13, 2022 | — |
| CORRESP | Letter to the SEC | Dec 12, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 7, 2022 | — |
| 425 | Form 425 | Dec 1, 2022 | — |
| S-4/A | Registration statement | Nov 22, 2022 | — |
| CORRESP | Letter to the SEC | Nov 21, 2022 | — |
| 8-K |
Current report
Change to shareholder rights
|
Nov 16, 2022 | Nov 15, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| UPLOAD | Letter from the SEC | Nov 9, 2022 | — |
| SEC STAFF LETTER | Filing | Oct 31, 2022 | — |
| 8-K |
Current report
Change to shareholder rights
|
Oct 31, 2022 | Oct 31, 2022 |
| S-4/A | Registration statement | Oct 24, 2022 | — |
| CORRESP | Letter to the SEC | Oct 21, 2022 | — |
| 425 | Current report | Oct 21, 2022 | — |
| 8-K |
Current report
Material agreement
|
Oct 21, 2022 | Oct 21, 2022 |
| UPLOAD | Letter from the SEC | Oct 13, 2022 | — |
| CORRESP | Letter to the SEC | Sep 23, 2022 | — |
| S-4/A | Amended registration statement | Sep 23, 2022 | — |
| 425 | Form 425 | Sep 20, 2022 | — |
| 425 | Form 425 | Sep 20, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 5, 2022 | — |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| S-4 | Registration for a merger or exchange | Aug 8, 2022 | — |
| 8-K |
Current report
Shareholder vote results
|
Jul 27, 2022 | Jul 26, 2022 |
| 8-K |
Current report
Other events
|
Jul 26, 2022 | Jul 22, 2022 |
| DEFA14A | Additional proxy material | Jul 18, 2022 | — |
| DEFA14A | Additional proxy material | Jul 12, 2022 | — |
| 425 | Filing | Jul 8, 2022 | — |
| 425 | Form 425 | Jul 5, 2022 | — |
| 425 | Filing | Jul 5, 2022 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jul 5, 2022 | Jul 4, 2022 |
| UPLOAD | Letter from the SEC | Jul 1, 2022 | — |
| DEF 14A | Proxy statement | Jul 1, 2022 | Jul 26, 2022 |
| CORRESP | Letter to the SEC | Jun 28, 2022 | — |
| PRER14A | Filing | Jun 28, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 27, 2022 | — |
| PRE 14A | Preliminary proxy statement | Jun 21, 2022 | Jun 21, 2022 |
| 10-Q | Quarterly report | May 13, 2022 | Mar 31, 2022 |
| 10-Q/A | Amended quarterly report | Mar 31, 2022 | Sep 30, 2021 |
| 10-K | Annual report | Mar 31, 2022 | Dec 31, 2021 |
| 10-K/A | Amended annual report | Mar 31, 2022 | Dec 31, 2020 |
| 8-K |
Current report
Restatement
|
Feb 10, 2022 | Feb 4, 2022 |
| 10-Q | Quarterly report | Nov 12, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 17, 2021 | Mar 31, 2021 |
| 10-K | Annual report | Mar 10, 2021 | Dec 31, 2020 |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Other events
|
Aug 12, 2020 | Aug 6, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
|
Aug 7, 2020 | Aug 3, 2020 |
| 424B4 | Prospectus | Aug 5, 2020 | — |
| CERT | Filing | Aug 4, 2020 | — |
| EFFECT | Filing | Aug 3, 2020 | — |
| S-1MEF | Registration statement | Aug 3, 2020 | — |
| 8-A12B | Form 8-a12b | Aug 3, 2020 | — |
| CORRESP | Letter to the SEC | Jul 30, 2020 | — |
| CORRESP | Letter to the SEC | Jul 30, 2020 | — |
| S-1/A | Amended registration statement | Jul 28, 2020 | — |
| S-1/A | Amended registration statement | Jul 24, 2020 | — |
| S-1 | Registration statement | Jul 17, 2020 | — |
| DRS | Filing | Jun 22, 2020 | — |
Showing 156 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- OBIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New Hope, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1814114
- Former names
- Health Sciences Acquisitions Corp 2 (until Jan 26, 2023)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.